Explore comprehensive CDMO services offered by Medigen Inc, supporting end-to-end Drug Development and Manufacturing. Medigen Inc enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A.
Description: Medigen, Inc. is a biopharmaceutical company based in Frederick, Maryland, that develops vaccines for infectious and chronic diseases using proprietary technologies like Virus-Like Particles and RNA Vectors. The company, founded in 2004, also provides contract research and development services. It has developed vaccines such as the V4020 live-attenuated vaccine for Venezuelan equine encephalitis virus (VEEV) and is collaborating on a chikungunya vaccine with the University of Louisville.
